$1.2501
-0.0399[-3.09%]
At close: Apr 24
$1.2501
0[0.00%]
PreMarket: 4:39PM EDT
Cyclo Therapeutics
(NASDAQ:CYTH)Latest News for Cyclo Therapeutics Stock (NASDAQ:CYTH)
Cyclo Therapeutics Stock (NASDAQ: CYTH)
Categories: All
Monday, April 22, 2024
Thursday, April 18, 2024
Tuesday, April 02, 2024
Monday, March 18, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
Monday, January 29, 2024
Monday, January 15, 2024
Thursday, December 28, 2023
Wednesday, December 27, 2023
Wednesday, November 15, 2023
Wednesday, November 08, 2023
Monday, November 06, 2023
Monday, October 23, 2023
Wednesday, September 27, 2023
Thursday, September 21, 2023
- Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Sep 21, 2023, 1:16PM
- Rare Disease Player Cyclo Therapeutics To Merge With Applied Molecular TransportVandana Singh - Sep 21, 2023, 9:46AM
- Cyclo Therapeutics shares are trading higher after the company and Applied Molecular Transport announced they entered into a definitive merger agreement.Benzinga Newsdesk - Sep 21, 2023, 8:38AM
- Cyclo Therapeutics And Applied Molecular Transport Enter Into A Definitive Merger Agreement In All-Stock Transaction; Operate Under Name "Cyclo Therapeutics" And Trading Under "CYTH"Benzinga Newsdesk - Sep 21, 2023, 8:08AM
Friday, September 08, 2023
Thursday, August 03, 2023
Wednesday, August 02, 2023
Thursday, June 29, 2023
Wednesday, June 14, 2023
Monday, June 12, 2023
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Jun 12, 2023, 9:06AM
- Cyclo Therapeutics shares are trading higher after European Patent Office allows patent for Trappsol Cyclo for Alzheimer's Disease.Benzinga Newsdesk - Jun 12, 2023, 8:18AM
- Cyclo Therapeutics Announces Notice Of Allowance For European Patent Titled 'Methods for Treating Alzheimer's Disease.'Benzinga Newsdesk - Jun 12, 2023, 8:07AM
Monday, June 05, 2023
Monday, May 15, 2023
Wednesday, April 26, 2023
Tuesday, April 25, 2023
Friday, April 21, 2023
Wednesday, April 12, 2023
Friday, April 07, 2023
Monday, April 03, 2023
Tuesday, March 21, 2023
Monday, March 20, 2023
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Mar 20, 2023, 1:31PM
- Cyclo Therapeutics Provides Business Update And Reports FY22 Financial Results; The Company Ended The Year With ~$1.5M Of Cash. Pro-forma Year End Cash Of $5.2M Post The Financing Completed On With Single Institutional Investor In January Of 2023Happy Mohamed - Mar 20, 2023, 8:13AM
Friday, March 10, 2023
- Cyclo Therapeutics Chief Financial Officer Awarded $44K Worth of Stock OptionsBenzinga Insights - Mar 10, 2023, 10:02AM
- Cyclo Therapeutics Board Member Awarded $3K Worth of Stock OptionsBenzinga Insights - Mar 10, 2023, 10:02AM
- Chief Executive Officer at Cyclo Therapeutics Acquires Company Stock Options Worth 98,706 SharesBenzinga Insights - Mar 10, 2023, 10:02AM
- Cyclo Therapeutics Chief Operating Officer Awarded $44K Worth of Stock OptionsBenzinga Insights - Mar 10, 2023, 10:02AM